Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy

PURPOSE: Hepatocellular carcinoma (HCC) is one of the most common fatal cancers, with no curative therapy available. The concept of ferroptosis is attracting increasing attention in cancer research. Herein, we describe the use of a nanodevice as an effective strategy for inducing ferroptosis to mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xianchuang, Zhu, Xinyang, Qi, Xun, Meng, Xianwei, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884959/
https://www.ncbi.nlm.nih.gov/pubmed/33603367
http://dx.doi.org/10.2147/IJN.S292528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884959/
https://www.ncbi.nlm.nih.gov/pubmed/33603367
http://dx.doi.org/10.2147/IJN.S292528

Ejemplares similares